nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—CYP1A2—Betaxolol—glaucoma	0.0263	0.646	CbGbCtD
Rizatriptan—CYP1A2—Clonidine—glaucoma	0.0144	0.354	CbGbCtD
Rizatriptan—Melatonin—CYP1B1—glaucoma	0.00311	1	CrCbGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000569	0.00725	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000564	0.0072	CbGpPWpGaD
Rizatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000557	0.00711	CbGpPWpGaD
Rizatriptan—Flushing—Betaxolol—glaucoma	0.00053	0.000603	CcSEcCtD
Rizatriptan—Pain—Dorzolamide—glaucoma	0.000528	0.000601	CcSEcCtD
Rizatriptan—Insomnia—Pilocarpine—glaucoma	0.000527	0.000601	CcSEcCtD
Rizatriptan—Decreased appetite—Brinzolamide—glaucoma	0.000527	0.000601	CcSEcCtD
Rizatriptan—Constipation—Travoprost—glaucoma	0.000525	0.000599	CcSEcCtD
Rizatriptan—Pain—Travoprost—glaucoma	0.000525	0.000599	CcSEcCtD
Rizatriptan—Agitation—Clonidine—glaucoma	0.000524	0.000597	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000524	0.000597	CcSEcCtD
Rizatriptan—Paraesthesia—Pilocarpine—glaucoma	0.000524	0.000597	CcSEcCtD
Rizatriptan—Asthenia—Bimatoprost—glaucoma	0.000524	0.000597	CcSEcCtD
Rizatriptan—Fatigue—Brinzolamide—glaucoma	0.000523	0.000596	CcSEcCtD
Rizatriptan—Angioedema—Clonidine—glaucoma	0.000521	0.000594	CcSEcCtD
Rizatriptan—Dyspnoea—Pilocarpine—glaucoma	0.00052	0.000592	CcSEcCtD
Rizatriptan—Pain—Brinzolamide—glaucoma	0.000519	0.000591	CcSEcCtD
Rizatriptan—Somnolence—Pilocarpine—glaucoma	0.000518	0.000591	CcSEcCtD
Rizatriptan—Angiopathy—Betaxolol—glaucoma	0.000518	0.00059	CcSEcCtD
Rizatriptan—Pruritus—Bimatoprost—glaucoma	0.000516	0.000588	CcSEcCtD
Rizatriptan—Diarrhoea—Apraclonidine—glaucoma	0.000515	0.000587	CcSEcCtD
Rizatriptan—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000514	0.00656	CbGpPWpGaD
Rizatriptan—Dyspepsia—Pilocarpine—glaucoma	0.000513	0.000585	CcSEcCtD
Rizatriptan—Chills—Betaxolol—glaucoma	0.000512	0.000583	CcSEcCtD
Rizatriptan—Syncope—Clonidine—glaucoma	0.000512	0.000583	CcSEcCtD
Rizatriptan—Arrhythmia—Betaxolol—glaucoma	0.00051	0.000581	CcSEcCtD
Rizatriptan—Feeling abnormal—Dorzolamide—glaucoma	0.000509	0.000579	CcSEcCtD
Rizatriptan—Decreased appetite—Pilocarpine—glaucoma	0.000507	0.000578	CcSEcCtD
Rizatriptan—Feeling abnormal—Travoprost—glaucoma	0.000506	0.000577	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Dorzolamide—glaucoma	0.000505	0.000575	CcSEcCtD
Rizatriptan—Palpitations—Clonidine—glaucoma	0.000504	0.000574	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000503	0.000574	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Travoprost—glaucoma	0.000502	0.000572	CcSEcCtD
Rizatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000502	0.0064	CbGpPWpGaD
Rizatriptan—Loss of consciousness—Clonidine—glaucoma	0.000502	0.000571	CcSEcCtD
Rizatriptan—Feeling abnormal—Brinzolamide—glaucoma	0.0005	0.00057	CcSEcCtD
Rizatriptan—Mental disorder—Betaxolol—glaucoma	0.0005	0.00057	CcSEcCtD
Rizatriptan—Pain—Pilocarpine—glaucoma	0.000499	0.000568	CcSEcCtD
Rizatriptan—Constipation—Pilocarpine—glaucoma	0.000499	0.000568	CcSEcCtD
Rizatriptan—Cough—Clonidine—glaucoma	0.000498	0.000567	CcSEcCtD
Rizatriptan—Sweating—Timolol—glaucoma	0.000498	0.000567	CcSEcCtD
Rizatriptan—Dizziness—Apraclonidine—glaucoma	0.000498	0.000567	CcSEcCtD
Rizatriptan—Erythema—Betaxolol—glaucoma	0.000497	0.000566	CcSEcCtD
Rizatriptan—Urticaria—Dorzolamide—glaucoma	0.00049	0.000559	CcSEcCtD
Rizatriptan—Epistaxis—Timolol—glaucoma	0.00049	0.000558	CcSEcCtD
Rizatriptan—Body temperature increased—Dorzolamide—glaucoma	0.000488	0.000556	CcSEcCtD
Rizatriptan—Abdominal pain—Dorzolamide—glaucoma	0.000488	0.000556	CcSEcCtD
Rizatriptan—Tension—Betaxolol—glaucoma	0.000487	0.000555	CcSEcCtD
Rizatriptan—HTR1D—GPCR ligand binding—OPN4—glaucoma	0.000487	0.00622	CbGpPWpGaD
Rizatriptan—Dysgeusia—Betaxolol—glaucoma	0.000486	0.000554	CcSEcCtD
Rizatriptan—Arthralgia—Clonidine—glaucoma	0.000486	0.000553	CcSEcCtD
Rizatriptan—Chest pain—Clonidine—glaucoma	0.000486	0.000553	CcSEcCtD
Rizatriptan—Abdominal pain—Travoprost—glaucoma	0.000486	0.000553	CcSEcCtD
Rizatriptan—Anxiety—Clonidine—glaucoma	0.000484	0.000552	CcSEcCtD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000483	0.00617	CbGpPWpGaD
Rizatriptan—Asthenia—Acetazolamide—glaucoma	0.000483	0.00055	CcSEcCtD
Rizatriptan—Dizziness—Bimatoprost—glaucoma	0.000483	0.00055	CcSEcCtD
Rizatriptan—Nervousness—Betaxolol—glaucoma	0.000482	0.00055	CcSEcCtD
Rizatriptan—Urticaria—Brinzolamide—glaucoma	0.000482	0.000549	CcSEcCtD
Rizatriptan—Feeling abnormal—Pilocarpine—glaucoma	0.000481	0.000547	CcSEcCtD
Rizatriptan—Discomfort—Clonidine—glaucoma	0.00048	0.000547	CcSEcCtD
Rizatriptan—Vomiting—Apraclonidine—glaucoma	0.000479	0.000545	CcSEcCtD
Rizatriptan—Muscle spasms—Betaxolol—glaucoma	0.000478	0.000544	CcSEcCtD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000477	0.00609	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—OPN4—glaucoma	0.000477	0.00609	CbGpPWpGaD
Rizatriptan—Gastrointestinal pain—Pilocarpine—glaucoma	0.000477	0.000543	CcSEcCtD
Rizatriptan—Hypersensitivity—Brimonidine—glaucoma	0.000476	0.000542	CcSEcCtD
Rizatriptan—Dry mouth—Clonidine—glaucoma	0.000475	0.000541	CcSEcCtD
Rizatriptan—Bradycardia—Timolol—glaucoma	0.000475	0.000541	CcSEcCtD
Rizatriptan—Dermatitis—Apraclonidine—glaucoma	0.000474	0.00054	CcSEcCtD
Rizatriptan—Headache—Apraclonidine—glaucoma	0.000472	0.000537	CcSEcCtD
Rizatriptan—Confusional state—Clonidine—glaucoma	0.00047	0.000535	CcSEcCtD
Rizatriptan—Vision blurred—Betaxolol—glaucoma	0.000468	0.000533	CcSEcCtD
Rizatriptan—Oedema—Clonidine—glaucoma	0.000466	0.000531	CcSEcCtD
Rizatriptan—Tremor—Betaxolol—glaucoma	0.000465	0.00053	CcSEcCtD
Rizatriptan—Hallucination—Timolol—glaucoma	0.000464	0.000528	CcSEcCtD
Rizatriptan—Asthenia—Brimonidine—glaucoma	0.000464	0.000528	CcSEcCtD
Rizatriptan—Body temperature increased—Pilocarpine—glaucoma	0.000461	0.000525	CcSEcCtD
Rizatriptan—Abdominal pain—Pilocarpine—glaucoma	0.000461	0.000525	CcSEcCtD
Rizatriptan—Diarrhoea—Acetazolamide—glaucoma	0.000461	0.000525	CcSEcCtD
Rizatriptan—Rash—Bimatoprost—glaucoma	0.00046	0.000524	CcSEcCtD
Rizatriptan—Dermatitis—Bimatoprost—glaucoma	0.00046	0.000524	CcSEcCtD
Rizatriptan—Shock—Clonidine—glaucoma	0.000458	0.000522	CcSEcCtD
Rizatriptan—Pruritus—Brimonidine—glaucoma	0.000457	0.000521	CcSEcCtD
Rizatriptan—Headache—Bimatoprost—glaucoma	0.000457	0.000521	CcSEcCtD
Rizatriptan—Nervous system disorder—Clonidine—glaucoma	0.000457	0.00052	CcSEcCtD
Rizatriptan—Hypersensitivity—Dorzolamide—glaucoma	0.000455	0.000518	CcSEcCtD
Rizatriptan—Tachycardia—Clonidine—glaucoma	0.000455	0.000518	CcSEcCtD
Rizatriptan—Hypersensitivity—Travoprost—glaucoma	0.000453	0.000516	CcSEcCtD
Rizatriptan—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000453	0.00577	CbGpPWpGaD
Rizatriptan—Hyperhidrosis—Clonidine—glaucoma	0.00045	0.000513	CcSEcCtD
Rizatriptan—MAOA—Neuronal System—SLC6A13—glaucoma	0.000449	0.00573	CbGpPWpGaD
Rizatriptan—Nausea—Apraclonidine—glaucoma	0.000447	0.000509	CcSEcCtD
Rizatriptan—Hypersensitivity—Brinzolamide—glaucoma	0.000447	0.000509	CcSEcCtD
Rizatriptan—Vertigo—Betaxolol—glaucoma	0.000446	0.000508	CcSEcCtD
Rizatriptan—Syncope—Betaxolol—glaucoma	0.000445	0.000508	CcSEcCtD
Rizatriptan—Dizziness—Acetazolamide—glaucoma	0.000445	0.000507	CcSEcCtD
Rizatriptan—Anorexia—Clonidine—glaucoma	0.000444	0.000506	CcSEcCtD
Rizatriptan—Asthenia—Dorzolamide—glaucoma	0.000443	0.000504	CcSEcCtD
Rizatriptan—Asthenia—Travoprost—glaucoma	0.000441	0.000502	CcSEcCtD
Rizatriptan—Palpitations—Betaxolol—glaucoma	0.000439	0.0005	CcSEcCtD
Rizatriptan—HTR1D—GPCR ligand binding—PTGFR—glaucoma	0.000439	0.0056	CbGpPWpGaD
Rizatriptan—Pruritus—Dorzolamide—glaucoma	0.000437	0.000497	CcSEcCtD
Rizatriptan—Loss of consciousness—Betaxolol—glaucoma	0.000437	0.000497	CcSEcCtD
Rizatriptan—Asthenia—Brinzolamide—glaucoma	0.000435	0.000496	CcSEcCtD
Rizatriptan—Pruritus—Travoprost—glaucoma	0.000435	0.000495	CcSEcCtD
Rizatriptan—Tinnitus—Timolol—glaucoma	0.000435	0.000495	CcSEcCtD
Rizatriptan—Cough—Betaxolol—glaucoma	0.000433	0.000494	CcSEcCtD
Rizatriptan—Nausea—Bimatoprost—glaucoma	0.000433	0.000494	CcSEcCtD
Rizatriptan—HTR1F—GPCR downstream signaling—OPN4—glaucoma	0.000431	0.00549	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00043	0.00548	CbGpPWpGaD
Rizatriptan—Hypersensitivity—Pilocarpine—glaucoma	0.00043	0.000489	CcSEcCtD
Rizatriptan—HTR1B—GPCR ligand binding—PTGFR—glaucoma	0.00043	0.00548	CbGpPWpGaD
Rizatriptan—Pruritus—Brinzolamide—glaucoma	0.000429	0.000489	CcSEcCtD
Rizatriptan—MAOA—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000429	0.00547	CbGpPWpGaD
Rizatriptan—Vomiting—Acetazolamide—glaucoma	0.000428	0.000488	CcSEcCtD
Rizatriptan—Dizziness—Brimonidine—glaucoma	0.000427	0.000487	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Clonidine—glaucoma	0.000424	0.000483	CcSEcCtD
Rizatriptan—Angiopathy—Timolol—glaucoma	0.000423	0.000482	CcSEcCtD
Rizatriptan—Arthralgia—Betaxolol—glaucoma	0.000423	0.000482	CcSEcCtD
Rizatriptan—Chest pain—Betaxolol—glaucoma	0.000423	0.000482	CcSEcCtD
Rizatriptan—Myalgia—Betaxolol—glaucoma	0.000423	0.000482	CcSEcCtD
Rizatriptan—Diarrhoea—Dorzolamide—glaucoma	0.000422	0.000481	CcSEcCtD
Rizatriptan—Headache—Acetazolamide—glaucoma	0.000422	0.000481	CcSEcCtD
Rizatriptan—Anxiety—Betaxolol—glaucoma	0.000421	0.00048	CcSEcCtD
Rizatriptan—Insomnia—Clonidine—glaucoma	0.000421	0.00048	CcSEcCtD
Rizatriptan—MAOA—Biological oxidations—GSTT1—glaucoma	0.000421	0.00537	CbGpPWpGaD
Rizatriptan—Diarrhoea—Travoprost—glaucoma	0.00042	0.000479	CcSEcCtD
Rizatriptan—Asthenia—Pilocarpine—glaucoma	0.000418	0.000477	CcSEcCtD
Rizatriptan—Paraesthesia—Clonidine—glaucoma	0.000418	0.000476	CcSEcCtD
Rizatriptan—Discomfort—Betaxolol—glaucoma	0.000418	0.000476	CcSEcCtD
Rizatriptan—Arrhythmia—Timolol—glaucoma	0.000416	0.000474	CcSEcCtD
Rizatriptan—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	0.000416	0.0053	CbGpPWpGaD
Rizatriptan—Dyspnoea—Clonidine—glaucoma	0.000415	0.000473	CcSEcCtD
Rizatriptan—Diarrhoea—Brinzolamide—glaucoma	0.000415	0.000473	CcSEcCtD
Rizatriptan—Somnolence—Clonidine—glaucoma	0.000414	0.000472	CcSEcCtD
Rizatriptan—Dry mouth—Betaxolol—glaucoma	0.000414	0.000471	CcSEcCtD
Rizatriptan—Pruritus—Pilocarpine—glaucoma	0.000413	0.00047	CcSEcCtD
Rizatriptan—Confusional state—Betaxolol—glaucoma	0.000409	0.000466	CcSEcCtD
Rizatriptan—Mental disorder—Timolol—glaucoma	0.000408	0.000465	CcSEcCtD
Rizatriptan—Dizziness—Dorzolamide—glaucoma	0.000408	0.000465	CcSEcCtD
Rizatriptan—Rash—Brimonidine—glaucoma	0.000407	0.000464	CcSEcCtD
Rizatriptan—Dermatitis—Brimonidine—glaucoma	0.000407	0.000464	CcSEcCtD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000407	0.00519	CbGpPWpGaD
Rizatriptan—Dizziness—Travoprost—glaucoma	0.000406	0.000463	CcSEcCtD
Rizatriptan—Erythema—Timolol—glaucoma	0.000406	0.000462	CcSEcCtD
Rizatriptan—Oedema—Betaxolol—glaucoma	0.000405	0.000462	CcSEcCtD
Rizatriptan—Headache—Brimonidine—glaucoma	0.000405	0.000461	CcSEcCtD
Rizatriptan—Decreased appetite—Clonidine—glaucoma	0.000405	0.000461	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Clonidine—glaucoma	0.000402	0.000458	CcSEcCtD
Rizatriptan—Fatigue—Clonidine—glaucoma	0.000402	0.000457	CcSEcCtD
Rizatriptan—Dizziness—Brinzolamide—glaucoma	0.000401	0.000457	CcSEcCtD
Rizatriptan—Nausea—Acetazolamide—glaucoma	0.0004	0.000456	CcSEcCtD
Rizatriptan—Diarrhoea—Pilocarpine—glaucoma	0.000399	0.000455	CcSEcCtD
Rizatriptan—Shock—Betaxolol—glaucoma	0.000399	0.000454	CcSEcCtD
Rizatriptan—Tension—Timolol—glaucoma	0.000398	0.000454	CcSEcCtD
Rizatriptan—Pain—Clonidine—glaucoma	0.000398	0.000454	CcSEcCtD
Rizatriptan—Constipation—Clonidine—glaucoma	0.000398	0.000454	CcSEcCtD
Rizatriptan—Nervous system disorder—Betaxolol—glaucoma	0.000398	0.000453	CcSEcCtD
Rizatriptan—Dysgeusia—Timolol—glaucoma	0.000397	0.000453	CcSEcCtD
Rizatriptan—Tachycardia—Betaxolol—glaucoma	0.000396	0.000451	CcSEcCtD
Rizatriptan—Nervousness—Timolol—glaucoma	0.000394	0.000449	CcSEcCtD
Rizatriptan—Vomiting—Dorzolamide—glaucoma	0.000392	0.000447	CcSEcCtD
Rizatriptan—Hyperhidrosis—Betaxolol—glaucoma	0.000392	0.000447	CcSEcCtD
Rizatriptan—HTR1F—Signaling by GPCR—OPN4—glaucoma	0.000391	0.00499	CbGpPWpGaD
Rizatriptan—Rash—Dorzolamide—glaucoma	0.000389	0.000443	CcSEcCtD
Rizatriptan—Dermatitis—Dorzolamide—glaucoma	0.000389	0.000443	CcSEcCtD
Rizatriptan—HTR1F—GPCR downstream signaling—PTGFR—glaucoma	0.000388	0.00495	CbGpPWpGaD
Rizatriptan—Rash—Travoprost—glaucoma	0.000387	0.000441	CcSEcCtD
Rizatriptan—Dermatitis—Travoprost—glaucoma	0.000387	0.000441	CcSEcCtD
Rizatriptan—Headache—Dorzolamide—glaucoma	0.000387	0.00044	CcSEcCtD
Rizatriptan—Anorexia—Betaxolol—glaucoma	0.000386	0.00044	CcSEcCtD
Rizatriptan—Vomiting—Brinzolamide—glaucoma	0.000386	0.000439	CcSEcCtD
Rizatriptan—Dizziness—Pilocarpine—glaucoma	0.000386	0.000439	CcSEcCtD
Rizatriptan—Headache—Travoprost—glaucoma	0.000385	0.000439	CcSEcCtD
Rizatriptan—Nausea—Brimonidine—glaucoma	0.000384	0.000437	CcSEcCtD
Rizatriptan—Feeling abnormal—Clonidine—glaucoma	0.000384	0.000437	CcSEcCtD
Rizatriptan—Rash—Brinzolamide—glaucoma	0.000383	0.000436	CcSEcCtD
Rizatriptan—Vision blurred—Timolol—glaucoma	0.000382	0.000436	CcSEcCtD
Rizatriptan—Dermatitis—Brinzolamide—glaucoma	0.000382	0.000435	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Clonidine—glaucoma	0.000381	0.000434	CcSEcCtD
Rizatriptan—Headache—Brinzolamide—glaucoma	0.00038	0.000433	CcSEcCtD
Rizatriptan—Angioedema—Timolol—glaucoma	0.000371	0.000422	CcSEcCtD
Rizatriptan—Vomiting—Pilocarpine—glaucoma	0.000371	0.000422	CcSEcCtD
Rizatriptan—Urticaria—Clonidine—glaucoma	0.00037	0.000421	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000369	0.000421	CcSEcCtD
Rizatriptan—Body temperature increased—Clonidine—glaucoma	0.000368	0.000419	CcSEcCtD
Rizatriptan—Abdominal pain—Clonidine—glaucoma	0.000368	0.000419	CcSEcCtD
Rizatriptan—Rash—Pilocarpine—glaucoma	0.000368	0.000419	CcSEcCtD
Rizatriptan—Dermatitis—Pilocarpine—glaucoma	0.000367	0.000418	CcSEcCtD
Rizatriptan—Insomnia—Betaxolol—glaucoma	0.000367	0.000418	CcSEcCtD
Rizatriptan—Nausea—Dorzolamide—glaucoma	0.000367	0.000418	CcSEcCtD
Rizatriptan—Headache—Pilocarpine—glaucoma	0.000365	0.000416	CcSEcCtD
Rizatriptan—Nausea—Travoprost—glaucoma	0.000365	0.000416	CcSEcCtD
Rizatriptan—Vertigo—Timolol—glaucoma	0.000365	0.000415	CcSEcCtD
Rizatriptan—Paraesthesia—Betaxolol—glaucoma	0.000364	0.000415	CcSEcCtD
Rizatriptan—Syncope—Timolol—glaucoma	0.000364	0.000415	CcSEcCtD
Rizatriptan—HTR1A—GPCR ligand binding—OPN4—glaucoma	0.000363	0.00464	CbGpPWpGaD
Rizatriptan—Dyspnoea—Betaxolol—glaucoma	0.000361	0.000412	CcSEcCtD
Rizatriptan—Nausea—Brinzolamide—glaucoma	0.00036	0.000411	CcSEcCtD
Rizatriptan—Palpitations—Timolol—glaucoma	0.000359	0.000409	CcSEcCtD
Rizatriptan—Dyspepsia—Betaxolol—glaucoma	0.000357	0.000407	CcSEcCtD
Rizatriptan—Loss of consciousness—Timolol—glaucoma	0.000357	0.000406	CcSEcCtD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000355	0.00453	CbGpPWpGaD
Rizatriptan—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	0.000355	0.00453	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000355	0.00453	CbGpPWpGaD
Rizatriptan—Cough—Timolol—glaucoma	0.000354	0.000403	CcSEcCtD
Rizatriptan—Decreased appetite—Betaxolol—glaucoma	0.000352	0.000402	CcSEcCtD
Rizatriptan—HTR1F—Signaling by GPCR—PTGFR—glaucoma	0.000352	0.00449	CbGpPWpGaD
Rizatriptan—Hypertension—Timolol—glaucoma	0.00035	0.000399	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Betaxolol—glaucoma	0.00035	0.000399	CcSEcCtD
Rizatriptan—Fatigue—Betaxolol—glaucoma	0.00035	0.000398	CcSEcCtD
Rizatriptan—Pain—Betaxolol—glaucoma	0.000347	0.000395	CcSEcCtD
Rizatriptan—Constipation—Betaxolol—glaucoma	0.000347	0.000395	CcSEcCtD
Rizatriptan—Nausea—Pilocarpine—glaucoma	0.000346	0.000395	CcSEcCtD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000346	0.00441	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR ligand binding—SMO—glaucoma	0.000346	0.00441	CbGpPWpGaD
Rizatriptan—Chest pain—Timolol—glaucoma	0.000346	0.000394	CcSEcCtD
Rizatriptan—Arthralgia—Timolol—glaucoma	0.000346	0.000394	CcSEcCtD
Rizatriptan—Myalgia—Timolol—glaucoma	0.000346	0.000394	CcSEcCtD
Rizatriptan—Anxiety—Timolol—glaucoma	0.000344	0.000392	CcSEcCtD
Rizatriptan—Hypersensitivity—Clonidine—glaucoma	0.000343	0.000391	CcSEcCtD
Rizatriptan—Discomfort—Timolol—glaucoma	0.000341	0.000389	CcSEcCtD
Rizatriptan—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	0.000338	0.00431	CbGpPWpGaD
Rizatriptan—Dry mouth—Timolol—glaucoma	0.000338	0.000385	CcSEcCtD
Rizatriptan—MAOA—Biological oxidations—CYP1B1—glaucoma	0.000335	0.00428	CbGpPWpGaD
Rizatriptan—Asthenia—Clonidine—glaucoma	0.000334	0.000381	CcSEcCtD
Rizatriptan—Feeling abnormal—Betaxolol—glaucoma	0.000334	0.000381	CcSEcCtD
Rizatriptan—Confusional state—Timolol—glaucoma	0.000334	0.00038	CcSEcCtD
Rizatriptan—HTR1F—Signaling Pathways—LRP12—glaucoma	0.000333	0.00425	CbGpPWpGaD
Rizatriptan—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000332	0.00424	CbGpPWpGaD
Rizatriptan—Oedema—Timolol—glaucoma	0.000331	0.000377	CcSEcCtD
Rizatriptan—Anaphylactic shock—Timolol—glaucoma	0.000331	0.000377	CcSEcCtD
Rizatriptan—Pruritus—Clonidine—glaucoma	0.000329	0.000375	CcSEcCtD
Rizatriptan—HTR1F—G alpha (i) signalling events—C3—glaucoma	0.000329	0.0042	CbGpPWpGaD
Rizatriptan—MAOA—Neuronal System—SLC6A1—glaucoma	0.000329	0.00419	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—PTGFR—glaucoma	0.000327	0.00417	CbGpPWpGaD
Rizatriptan—Shock—Timolol—glaucoma	0.000326	0.000371	CcSEcCtD
Rizatriptan—Nervous system disorder—Timolol—glaucoma	0.000325	0.00037	CcSEcCtD
Rizatriptan—Urticaria—Betaxolol—glaucoma	0.000322	0.000367	CcSEcCtD
Rizatriptan—Body temperature increased—Betaxolol—glaucoma	0.000321	0.000365	CcSEcCtD
Rizatriptan—Hyperhidrosis—Timolol—glaucoma	0.00032	0.000365	CcSEcCtD
Rizatriptan—Diarrhoea—Clonidine—glaucoma	0.000319	0.000363	CcSEcCtD
Rizatriptan—Anorexia—Timolol—glaucoma	0.000316	0.00036	CcSEcCtD
Rizatriptan—Dizziness—Clonidine—glaucoma	0.000308	0.000351	CcSEcCtD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000304	0.00388	CbGpPWpGaD
Rizatriptan—Musculoskeletal discomfort—Timolol—glaucoma	0.000302	0.000344	CcSEcCtD
Rizatriptan—Insomnia—Timolol—glaucoma	0.0003	0.000341	CcSEcCtD
Rizatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000299	0.00382	CbGpPWpGaD
Rizatriptan—Hypersensitivity—Betaxolol—glaucoma	0.000299	0.00034	CcSEcCtD
Rizatriptan—Paraesthesia—Timolol—glaucoma	0.000297	0.000339	CcSEcCtD
Rizatriptan—Vomiting—Clonidine—glaucoma	0.000296	0.000337	CcSEcCtD
Rizatriptan—Dyspnoea—Timolol—glaucoma	0.000295	0.000336	CcSEcCtD
Rizatriptan—MAOA—Metabolism—CA5A—glaucoma	0.000295	0.00376	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—NARFL—glaucoma	0.000295	0.00376	CbGpPWpGaD
Rizatriptan—Somnolence—Timolol—glaucoma	0.000294	0.000335	CcSEcCtD
Rizatriptan—Rash—Clonidine—glaucoma	0.000294	0.000335	CcSEcCtD
Rizatriptan—Dermatitis—Clonidine—glaucoma	0.000293	0.000334	CcSEcCtD
Rizatriptan—Headache—Clonidine—glaucoma	0.000292	0.000332	CcSEcCtD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000292	0.00372	CbGpPWpGaD
Rizatriptan—Dyspepsia—Timolol—glaucoma	0.000292	0.000332	CcSEcCtD
Rizatriptan—Asthenia—Betaxolol—glaucoma	0.000291	0.000331	CcSEcCtD
Rizatriptan—Decreased appetite—Timolol—glaucoma	0.000288	0.000328	CcSEcCtD
Rizatriptan—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000287	0.00367	CbGpPWpGaD
Rizatriptan—Pruritus—Betaxolol—glaucoma	0.000287	0.000327	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Timolol—glaucoma	0.000286	0.000326	CcSEcCtD
Rizatriptan—Fatigue—Timolol—glaucoma	0.000286	0.000325	CcSEcCtD
Rizatriptan—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000284	0.00362	CbGpPWpGaD
Rizatriptan—Pain—Timolol—glaucoma	0.000283	0.000323	CcSEcCtD
Rizatriptan—Diarrhoea—Betaxolol—glaucoma	0.000277	0.000316	CcSEcCtD
Rizatriptan—Nausea—Clonidine—glaucoma	0.000277	0.000315	CcSEcCtD
Rizatriptan—HTR1D—GPCR downstream signaling—OPN4—glaucoma	0.000275	0.00351	CbGpPWpGaD
Rizatriptan—Feeling abnormal—Timolol—glaucoma	0.000273	0.000311	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Timolol—glaucoma	0.000271	0.000309	CcSEcCtD
Rizatriptan—HTR1B—GPCR downstream signaling—OPN4—glaucoma	0.00027	0.00344	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—NGF—glaucoma	0.00027	0.00344	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000268	0.00342	CbGpPWpGaD
Rizatriptan—MAOA—Biological oxidations—GSTM1—glaucoma	0.000268	0.00342	CbGpPWpGaD
Rizatriptan—Dizziness—Betaxolol—glaucoma	0.000268	0.000305	CcSEcCtD
Rizatriptan—CYP1A2—Phase II conjugation—GSTT1—glaucoma	0.000265	0.00339	CbGpPWpGaD
Rizatriptan—Urticaria—Timolol—glaucoma	0.000263	0.0003	CcSEcCtD
Rizatriptan—Body temperature increased—Timolol—glaucoma	0.000262	0.000298	CcSEcCtD
Rizatriptan—Abdominal pain—Timolol—glaucoma	0.000262	0.000298	CcSEcCtD
Rizatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000262	0.00334	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000258	0.00329	CbGpPWpGaD
Rizatriptan—Vomiting—Betaxolol—glaucoma	0.000258	0.000294	CcSEcCtD
Rizatriptan—Rash—Betaxolol—glaucoma	0.000256	0.000291	CcSEcCtD
Rizatriptan—Dermatitis—Betaxolol—glaucoma	0.000255	0.000291	CcSEcCtD
Rizatriptan—Headache—Betaxolol—glaucoma	0.000254	0.000289	CcSEcCtD
Rizatriptan—HTR1D—Signaling by GPCR—OPN4—glaucoma	0.00025	0.00319	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—PTGFR—glaucoma	0.000248	0.00316	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000248	0.00316	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—OPN4—glaucoma	0.000245	0.00312	CbGpPWpGaD
Rizatriptan—Hypersensitivity—Timolol—glaucoma	0.000244	0.000278	CcSEcCtD
Rizatriptan—HTR1B—GPCR downstream signaling—PTGFR—glaucoma	0.000243	0.0031	CbGpPWpGaD
Rizatriptan—Nausea—Betaxolol—glaucoma	0.000241	0.000274	CcSEcCtD
Rizatriptan—Asthenia—Timolol—glaucoma	0.000238	0.000271	CcSEcCtD
Rizatriptan—Pruritus—Timolol—glaucoma	0.000234	0.000267	CcSEcCtD
Rizatriptan—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000233	0.00297	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—OPN4—glaucoma	0.000231	0.00295	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—NGF—glaucoma	0.000229	0.00292	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000228	0.00291	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR ligand binding—EDN1—glaucoma	0.000228	0.00291	CbGpPWpGaD
Rizatriptan—Diarrhoea—Timolol—glaucoma	0.000227	0.000258	CcSEcCtD
Rizatriptan—HTR1D—Signaling by GPCR—PTGFR—glaucoma	0.000225	0.00287	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—SMO—glaucoma	0.000221	0.00282	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—PTGFR—glaucoma	0.00022	0.00281	CbGpPWpGaD
Rizatriptan—Dizziness—Timolol—glaucoma	0.000219	0.00025	CcSEcCtD
Rizatriptan—HTR1B—GPCR ligand binding—SMO—glaucoma	0.000217	0.00276	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—HEYL—glaucoma	0.000215	0.00274	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—LRP12—glaucoma	0.000213	0.00272	CbGpPWpGaD
Rizatriptan—Vomiting—Timolol—glaucoma	0.000211	0.00024	CcSEcCtD
Rizatriptan—HTR1D—G alpha (i) signalling events—C3—glaucoma	0.00021	0.00268	CbGpPWpGaD
Rizatriptan—Rash—Timolol—glaucoma	0.000209	0.000238	CcSEcCtD
Rizatriptan—HTR1B—Signaling Pathways—LRP12—glaucoma	0.000209	0.00266	CbGpPWpGaD
Rizatriptan—Dermatitis—Timolol—glaucoma	0.000209	0.000238	CcSEcCtD
Rizatriptan—HTR1F—Signaling Pathways—PTGFR—glaucoma	0.000208	0.00265	CbGpPWpGaD
Rizatriptan—Headache—Timolol—glaucoma	0.000207	0.000236	CcSEcCtD
Rizatriptan—HTR1B—G alpha (i) signalling events—C3—glaucoma	0.000206	0.00263	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—OPN4—glaucoma	0.000205	0.00262	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR ligand binding—C3—glaucoma	0.000199	0.00254	CbGpPWpGaD
Rizatriptan—Nausea—Timolol—glaucoma	0.000197	0.000224	CcSEcCtD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000192	0.00244	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000188	0.00239	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—OPN4—glaucoma	0.000187	0.00238	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—PTGFR—glaucoma	0.000185	0.00236	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—SMO—glaucoma	0.000178	0.00226	CbGpPWpGaD
Rizatriptan—CYP1A2—Phase II conjugation—GSTM1—glaucoma	0.000169	0.00216	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PTGFR—glaucoma	0.000168	0.00214	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000167	0.00213	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—SMO—glaucoma	0.000165	0.00211	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000164	0.00209	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—RPTOR—glaucoma	0.000163	0.00208	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.00016	0.00204	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—LRP12—glaucoma	0.000159	0.00203	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NCK2—glaucoma	0.000158	0.00201	CbGpPWpGaD
Rizatriptan—HTR1A—G alpha (i) signalling events—C3—glaucoma	0.000157	0.002	CbGpPWpGaD
Rizatriptan—CYP1A2—Biological oxidations—GSTT1—glaucoma	0.000155	0.00198	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000152	0.00194	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000152	0.00194	CbGpPWpGaD
Rizatriptan—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	0.00015	0.00191	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—OPN4—glaucoma	0.000148	0.00188	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—EDN1—glaucoma	0.000146	0.00186	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—OPN4—glaucoma	0.000145	0.00185	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CA1—glaucoma	0.000144	0.00184	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000143	0.00182	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—EDN1—glaucoma	0.000143	0.00182	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CTSA—glaucoma	0.00014	0.00178	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HEYL—glaucoma	0.000137	0.00175	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HEYL—glaucoma	0.000134	0.00172	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—HDAC9—glaucoma	0.000134	0.00171	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PTGFR—glaucoma	0.000133	0.0017	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CA2—glaucoma	0.000132	0.00168	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PTGFR—glaucoma	0.00013	0.00166	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—EDN1—glaucoma	0.000129	0.00164	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000129	0.00164	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—C3—glaucoma	0.000127	0.00163	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000126	0.00161	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000125	0.00159	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—C3—glaucoma	0.000125	0.00159	CbGpPWpGaD
Rizatriptan—CYP1A2—Biological oxidations—CYP1B1—glaucoma	0.000124	0.00158	CbGpPWpGaD
Rizatriptan—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	0.000122	0.00156	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—EDN1—glaucoma	0.000117	0.00149	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000116	0.00147	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—SMO—glaucoma	0.000114	0.00145	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—C3—glaucoma	0.000113	0.00144	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—SMO—glaucoma	0.000111	0.00142	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—TNF—glaucoma	0.00011	0.00141	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—OPN4—glaucoma	0.00011	0.00141	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000109	0.0014	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NARFL—glaucoma	0.000109	0.00139	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CA5A—glaucoma	0.000109	0.00139	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—EDN1—glaucoma	0.000109	0.00139	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	0.000108	0.00138	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.000108	0.00138	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—SMO—glaucoma	0.000105	0.00134	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—RPTOR—glaucoma	0.000104	0.00133	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HEYL—glaucoma	0.000102	0.00131	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—C3—glaucoma	0.000102	0.0013	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—RPTOR—glaucoma	0.000102	0.0013	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NCK2—glaucoma	0.000101	0.00129	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PTGFR—glaucoma	9.92e-05	0.00127	CbGpPWpGaD
Rizatriptan—CYP1A2—Biological oxidations—GSTM1—glaucoma	9.89e-05	0.00126	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NCK2—glaucoma	9.87e-05	0.00126	CbGpPWpGaD
Rizatriptan—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	9.76e-05	0.00124	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NTRK2—glaucoma	9.59e-05	0.00122	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—C3—glaucoma	9.5e-05	0.00121	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—TNF—glaucoma	9.38e-05	0.0012	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—TXN—glaucoma	9.29e-05	0.00118	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HDAC9—glaucoma	8.57e-05	0.00109	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—SMO—glaucoma	8.47e-05	0.00108	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HDAC9—glaucoma	8.39e-05	0.00107	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—EDN1—glaucoma	8.24e-05	0.00105	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NGFR—glaucoma	8.23e-05	0.00105	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—EDN1—glaucoma	8.07e-05	0.00103	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NTRK1—glaucoma	7.82e-05	0.000998	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—RPTOR—glaucoma	7.76e-05	0.00099	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NCK2—glaucoma	7.52e-05	0.000959	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—EDN1—glaucoma	7.48e-05	0.000955	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—EDN1—glaucoma	7.33e-05	0.000935	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CDKN2B—glaucoma	7.21e-05	0.000919	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GSTT1—glaucoma	7.2e-05	0.000919	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—C3—glaucoma	7.2e-05	0.000919	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—C3—glaucoma	7.05e-05	0.000899	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—EDN1—glaucoma	6.91e-05	0.000882	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—SMO—glaucoma	6.71e-05	0.000856	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—SMO—glaucoma	6.57e-05	0.000838	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—C3—glaucoma	6.54e-05	0.000834	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—C3—glaucoma	6.4e-05	0.000817	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HDAC9—glaucoma	6.39e-05	0.000816	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NGF—glaucoma	6.35e-05	0.000811	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—EDN1—glaucoma	6.15e-05	0.000784	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NTRK2—glaucoma	6.13e-05	0.000783	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—C3—glaucoma	6.04e-05	0.000771	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NTRK2—glaucoma	6.01e-05	0.000766	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CYP1B1—glaucoma	5.74e-05	0.000732	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ABCA1—glaucoma	5.74e-05	0.000732	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—APOE—glaucoma	5.62e-05	0.000717	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—EDN1—glaucoma	5.58e-05	0.000712	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CAV1—glaucoma	5.57e-05	0.000711	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—C3—glaucoma	5.37e-05	0.000685	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CA1—glaucoma	5.31e-05	0.000678	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—FN1—glaucoma	5.3e-05	0.000677	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NGFR—glaucoma	5.26e-05	0.000671	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—BAD—glaucoma	5.24e-05	0.000668	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NGFR—glaucoma	5.15e-05	0.000657	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CTSA—glaucoma	5.15e-05	0.000657	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SMO—glaucoma	5e-05	0.000638	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NTRK1—glaucoma	5e-05	0.000638	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NTRK1—glaucoma	4.9e-05	0.000625	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—C3—glaucoma	4.88e-05	0.000622	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CA2—glaucoma	4.86e-05	0.00062	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.75e-05	0.000606	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.75e-05	0.000606	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CDKN2B—glaucoma	4.61e-05	0.000588	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GSTM1—glaucoma	4.59e-05	0.000585	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NTRK2—glaucoma	4.58e-05	0.000584	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CDKN2B—glaucoma	4.51e-05	0.000576	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—EDN1—glaucoma	4.42e-05	0.000564	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—EDN1—glaucoma	4.33e-05	0.000552	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NOS3—glaucoma	4.21e-05	0.000537	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NGF—glaucoma	4.06e-05	0.000518	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—MTHFR—glaucoma	4.05e-05	0.000517	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NGF—glaucoma	3.98e-05	0.000508	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NGFR—glaucoma	3.93e-05	0.000501	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—C3—glaucoma	3.86e-05	0.000493	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—C3—glaucoma	3.78e-05	0.000483	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—APOE—glaucoma	3.77e-05	0.000481	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CAV1—glaucoma	3.74e-05	0.000477	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NTRK1—glaucoma	3.73e-05	0.000476	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CDKN1B—glaucoma	3.65e-05	0.000466	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—APOE—glaucoma	3.6e-05	0.000459	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CAV1—glaucoma	3.56e-05	0.000455	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—APOE—glaucoma	3.52e-05	0.000449	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CAV1—glaucoma	3.49e-05	0.000445	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CDKN2B—glaucoma	3.44e-05	0.000438	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—TXN—glaucoma	3.42e-05	0.000437	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—FN1—glaucoma	3.39e-05	0.000433	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MMP9—glaucoma	3.38e-05	0.000431	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—BAD—glaucoma	3.35e-05	0.000427	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—FN1—glaucoma	3.32e-05	0.000424	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EDN1—glaucoma	3.3e-05	0.000421	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—BAD—glaucoma	3.28e-05	0.000419	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.13e-05	0.000399	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.1e-05	0.000395	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—VEGFA—glaucoma	3.03e-05	0.000387	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NGF—glaucoma	3.03e-05	0.000387	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—C3—glaucoma	2.88e-05	0.000368	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—NOS3—glaucoma	2.83e-05	0.000361	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NOS3—glaucoma	2.69e-05	0.000344	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—APOE—glaucoma	2.68e-05	0.000342	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CAV1—glaucoma	2.66e-05	0.000339	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTT1—glaucoma	2.66e-05	0.000339	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NOS3—glaucoma	2.64e-05	0.000337	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PTGS2—glaucoma	2.59e-05	0.00033	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FN1—glaucoma	2.53e-05	0.000323	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—BAD—glaucoma	2.5e-05	0.000319	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CDKN1B—glaucoma	2.33e-05	0.000298	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TP53—glaucoma	2.29e-05	0.000293	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CDKN1B—glaucoma	2.29e-05	0.000292	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MMP9—glaucoma	2.16e-05	0.000276	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.14e-05	0.000273	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MMP9—glaucoma	2.12e-05	0.00027	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP1B1—glaucoma	2.12e-05	0.00027	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ABCA1—glaucoma	2.12e-05	0.00027	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NOS3—glaucoma	2.01e-05	0.000256	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—VEGFA—glaucoma	1.94e-05	0.000248	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—VEGFA—glaucoma	1.9e-05	0.000242	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CDKN1B—glaucoma	1.74e-05	0.000222	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTM1—glaucoma	1.69e-05	0.000216	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MMP9—glaucoma	1.61e-05	0.000206	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—MTHFR—glaucoma	1.49e-05	0.000191	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TP53—glaucoma	1.47e-05	0.000187	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—VEGFA—glaucoma	1.45e-05	0.000185	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TP53—glaucoma	1.44e-05	0.000183	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—APOE—glaucoma	1.39e-05	0.000178	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CAV1—glaucoma	1.38e-05	0.000176	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TP53—glaucoma	1.09e-05	0.00014	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NOS3—glaucoma	1.04e-05	0.000133	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PTGS2—glaucoma	9.54e-06	0.000122	CbGpPWpGaD
